INTRODUCTION
Thyroid nodules are a common clinical problem in the German population; they are detected in about 30 % (1) . Despite this relatively high prevalence most nodules are benign, only 0.1 % of all malignant neoplasms are thyroid carcinomas (1) . Nonetheless, benign nodules can cause problems as well, namely subjective symptoms, cosmetic concerns or even the fear of a malignant transformation (2) . Ultrasound guided percutaneous microwave ablation (MWA) is a new minimally invasive treatment, which provides an alternative to conventional treatments for benign thyroid nodules such as surgical excision and radioiodine therapy, as well as for other thermal ablation techniques e.g. radiofrequency ablation (RFA) (3) (4) (5) . Even though MWA represents a recent treatment approach in the 1ield of thyroid nodules, it has already been used successfully for the treatment of other parenchyma as liver, lung and kidney (6) 
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already been presented in several studies (3) (4) (5) . . Microwave ablation offers various advantages in comparison to other thermal ablation techniques as, for example, the ability to generate larger ablation zones, a shorter ablation time and a lower susceptibility to heat sinks (7) (8) (9) . While scintigraphy is well established in assessing the consistency of thyroid nodules (10) , its usage for validation of thermal ablation has not been described so far. Different studies showed possible disadvantages of ultrasound in evaluating the effects of thermal ablation such as underestimating the size of the ablation area and representing a falsi1ied conformation of this area (11, 12) . Evaluating the result of microwave ablation or of other thermal ablation techniques using scintigraphy imaging is a new approach. To our knowledge, there are no studies discussing the possible advantages of functional imaging for evaluation of MWA so far.
The aim of this study was to de1ine observable alterations of thyroid tissue after microwave ablation by functional scintigraphy and to evaluate the feasibility of this diagnostic tool for follow-up of microwave ablated benign thyroid nodules.
MATERIALS AND METHODS

Patients
Thirty patients with overall forty benign thyroid nodules were treated with MWA (16 men, 14 women; median age 56 years, range 31 to 81 years). Inclusion criteria were: (a) nodule-related clinical problems such as throat tightness, hoarseness, swallowing disorders, neck pain, discomfort or thyrotoxicosis, (b) refusal of surgical treatment, (c) contraindications to surgery. This type of treatment can also be used for (d) cosmetic problems caused by thyroid nodules.
The following contraindications can be speci1ied: Patients with (a) malignant nodules, (b) histological indication of follicular proliferation and (c) atypical 1indings in 99m Tc-MIBI in cold thyroid nodules were excluded from treatment. Patients with (d) thyroid nodules in critical locations (positions of vessels, nerves, trachea and esophagus), (e) nodules with dominantly cystic composition were also excluded from participation.
The local Ethics Committee approved this retrospective study and a written informed consent was obtained from all patients before treatment.
MWA equipment
The generator used in this study (Avecure MWG881, Med Waves, Inc., San Diego, CA) is operating with frequencies within the range of 902 to 928 MHz. Three probes with ablation zones of different sizes (14-16 G) were used depending on nodule volume and individual anatomical conditions of each patient. The 1ield size varied from 1 cm to 4 cm. In order to avoid overheating, the microwave probe possesses an integrated temperature sensor, which restrains a potential heating-up after the target temperature is reached. The 99m Tc-MIBI imaging was performed using a thyroid speci1ic gamma camera (Mediso Nucline ® TH/22) with an acquisition time of 500 s, an acquisition matrix of 256 × 256 × 16 and a LETH collimator. The same gamma camera was used for 99m Tc-pertechnetate scintigraphy. The acquisition duration was 300 s, and an acquisition matrix of 128 × 128 × 16 was used.
Pre-ablation assessment
Prior to the actual microwave ablation, size, volume, consistency and the exact location of the nodules were determined by ultrasound. The nodules were categorized as echo-solid, echo-cystic or echo-complex (both solid and cystic). In addition the exact position, the capacity of ablation and the type of vagus nerve was identi1ied (13) . Additionally, functional imaging of the nodule activity was performed by 99m Tc-pertechnetate scintigraphy in all patients. 20 minutes after injection of 75 MBq 99m Tcpertechnetate, the guideline compliant imaging was accomplished. In thyroid nodules detected as cold by prior scintigraphy, a 99m Tc-MIBI scintigraphy imaging and a 1ine needle aspiration cytology of the nodular tissue with subsequent pathological examination was performed to exclude malignancy. 99m Tc-MIBI scans were taken 10 and 60 minutes after injection of 500 MBq 99m Tc-MIBI. Quantitative ROI-analysis was performed using ROIs covering the global thyroid, the cold nodules and a background-ROI in the pre-and post-therapeutic images (software: Mediso Interview XP ® ). After area adapted background corrections of the count rates, the intranodular uptake was calculated pre-and post-therapeutically and related to the global uptake of the whole thyroid gland. Moreover, microwave induced percentage change of uptake was detected as a quotient of pre-and post-therapeutic (1igure 1). Multiple benign nodules were assessed in the same scan.
MWA procedure
The intervention was performed under local anesthesia and aseptic conditions. Each patient was treated in a supine position with extended neck. In order to reduce possible pain, the patients received 40 drops of Novalgin. Before the ablation started, a local in1iltration of Scandicain 1% was performed to reduce pain and to enlarge the distance between skin and ablation zone. The general approach of transithmic access was chosen in order to make the display of the whole length of the probe easier.
If it was not possible to reach the thyroid nodule through the transisthmic path, a craniocaudal access was chosen. The microwave probe was inserted under sonographic guidance. The ablation was performed starting
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from the deepest part of the thyroid nodule to the super1icial zone. To reduce risks of treatment signi1icantly, the moving-shottechnique was used (2) . Heating of the thyroid tissue leads to the emergence of transient hyperechoic zones (observable via ultrasound) which can be used as a control during the ablation procedure (14) . In case of perception of pain, target temperature was decreased during the ablation procedure.
Ef icacy evaluation and follow-up
24 hours after ablation, the post-treatment thyroid imaging was performed. Patients with cold nodules received another 99m Tc-MIBI imaging; patients with indifferent nodules (neither hot nor cold) another 99m Tcpertechnetate imaging. Additionally, B-mode ultrasound was performed to exclude any local complications. 3 monthsafter MWA volume changes were assessed.
Statistical analysis
All statistical analyses were performed with dedicated software (BiAS. ® 10.04 for Windows, epsilon-Verlag).
The post-interventional radionuclide uptake of nodular tissue was compared in relation to the pre-interventional uptake. Due to nonsymmetric distribution of 99m Tc-MIBI-and 99m Tcpertechnetate uptake, non-parametric statistics was used on these data. Averaged measurements for the uptake-reduction are expressed as median. Signi1icant differences of pre-and post- 
RESULTS
In all ablation sessions, the therapy could be fully completed, and the entire nodule volume was ablated. Fifteen nodules were solid and twenty-1ive complex. Dominantly cystic nodules were excluded from this study. Twenty-seven cold and thirteen indifferent nodules were treated. The respective time of ablation ranged between 300 and 1500 seconds per patient and 120 and 300 seconds per ablation zone. On an average, each patient was treated for 600 seconds with a median output of 28 W (range 24 to 36 Watt). Post-interventional 99m Tcpertechnetate and 99m Tc-MIBI scintigraphy showed that the uptake in ablated thyroid areas decreased (1igure 2, 1igure 3). At a 3-month follow-up all patients showed a signi1icant decrease of nodule volume. The median volume reduction was 7.8 ml or 50.34 % (p < 0.01).
A correlation between the uptake reduction in 99m Tc-MIBI scans and volume reduction could not be allocated. A correlation between uptake reduction in 99m Tc-pertechnetate scans and volume reduction could not be found either . Tc-pertechnetate prior to (A) and a=er microwave abla on (B). In the ablated area tracer uptake is decreased a=er MWA (circle). Tc-MIBI imaging before and a=er MWA. Scin graphic imaging using Tc -MIBI prior to (A) and a=er microwave abla on (B). In the ablated areab tracer uptake is decreased a=er MWA (circle). 
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DISCUSSION
The 1indings of this study suggest, that functional imaging with 99m Tc-pertechnetate and 9 9m Tc-MIBI shows molecular-based and early-phase changes in the ablation area after microwave ablation of benign thyroid nodules. For both tracers, a signi1icant uptake reduction could be shown. The effectiveness of MWA, as an alternative treatment option for benign thyroid nodules, has been shown in several studies before (3) (4) (5) . Therefore, the aim of this study was not to prove the effects of MWA on thyroid tissue in general but to evaluate how ef1iciently those effects can be detected and quali1ied using scintigraphy. In previous studies about RFA or MWA ultrasound or Doppler was used to assess treatment outcome. A signi1icant advantage of sodium iodine symporter in thyroid tissue (22) ; like iodine itself 99m Tc-pertechnetate is carried into iodine storing cells. The scintigraphy 1indings of this study show a signi1icant decrease of tracer uptake after microwave ablation (1igure 4). The uptake was reduced by 39 %. Temperatures during MWA rise above 43 °C , causing injury to cell morphology and ion channels (23) , the sodium iodine symporter and iodine storing tissue must be destroyed. Subsequently, scintigraphy shows a reduced tracer uptake in the ablation area (1igure 2). Baek et al. (24) showed similar 1indings after RFA for autonomously functioning thyroid nodules.
For cold nodules, without any uptake of 99m Tc-pertechnetate, 99m Tc-MIBI was used for evaluation. A signi1icant reduction of tracer uptake could be shown for 99m Tc-MIBI as well (1igure 5). For 99m Tc-MIBI, the uptake reduced by 40 %. 99m99m Tc-MIBI accumulates in sound mitochondria with an intact membrane potential (25) . As can be seen in 1igure 3, there is no 99m Tc-MIBI uptake within the ablation area after MWA, the necrosis induced by MWA must have destroyed the mitochondrial membrane potential and mitochondria itself. The 1indings of this study show that 99m Tc-MIBI enables a functional evaluation after thermal ablation even for cold nodules. A previously released case report con1irmed these 1indings (26) .
Functional imaging was used to detect effects within the early postablative period. As previously described (22, 25) , tracer uptake is dependent on molecular processes. The molecular-based changes leading to an uptake reduction may display necrosis even before morphological changes can happen. Thus, by using 99m Tc-MIBI or 99m Tc-pertechnetate scintigraphy , it is possible to evaluate MWA almost instantly following the treatment, whereas sonography and ultrasound are not capable of detecting these early molecular changes. Moreover and contrary to sonography, scintigraphy offers the advantage of assessing the ablated thyroid tissue morphologically as well as functionally (26, 27) . The procedure supplies prompt information about the global functional status of the thyroid and the local activity within the area of the treated tissue (5, 26, using ultrasound in order to visualize treatment outcome of thermal ablation is the fact that sonography does not require any patient preparation. Furthermore, this method is easy to perform and cost-effective (15, 16) , especially when compared to other imaging methods as MR scans or scintigraphy. Nevertheless, ultrasound can only detect morphological changes of thyroid nodules. A functional evaluation of the treated area is not possible. Subsequent to the ablation, a period of several months is required in order to degrade the necrotic ablated tissue endogenously. In addition, Andrioli et al. (17) stated that an immediate evaluation of lesions treated with radiofrequency or laser ablation by ultrasound is not possible "due to tissue in1iltration by gas as a result of tissue vaporization". Sonography, and Doppler ultrasound, are susceptible to artefacts, so called "microbubbles", that appear in the ablation area during thermoablation (14, 18) , limiting the diagnostic accuracy in early postablative phases.
Furthermore, studies show that B-mode ultrasound is not absolutely appropriate to assess MWA outcome. Zhou et al. (11) showed that sonography does not re1lect the true conformation of lesions due to thermal ablation. Wiggermann et al. (16) stated that with ultrasound the necrotic area cannot be clearly de1ined whilst ablation due to poor contrast between untreated and treated tissue. Correa-Gallego et al. (12) even showed, that ultrasound and elastography signi1icantly underestimate the size of the area treated with RFA as the degree of cell injury cannot be displayed with these methods. This study was on RFA in in-vivo porcine liver tissue; Pareek et al. (19) showed similar 1indings in kidney tissue.
Scintigraphy imaging still is a crucial device for the characterization of thyroid pathologies; even innovations in other diagnostic techniques have not been able to reduce the importance of scintigraphy in the diagnose of thyroid diseases (10, 20, 21) .
In this study, two traces were used: 99m Tc (27) con1irmed, that "scintigraphy is the only diagnostic method that can make a conclusive comparative analysis of results before and after microwave ablation during follow-up". As radioactive devices should be used reasonably, additional studies are required in order to con1irm the ef1icacy of this method. Moreover, longer follow-up periods are needed to prove in how far scintigraphy can be considered as a conclusive diagnostic method for long-term treatment success.
CONCLUSION
Functional imaging shows early-phase and molecular-based changes of the ablation area, these cannot be seen in ultrasound measurement. Scintigraphy displays a potential device for functional veri1ication of MWA. Further studies are necessary to prove the bene1it of functional imaging.
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